参考文献/References:
[1] 郭娟莉,李春鸟.红光照射对慢性湿疹的治疗效果研究[J].陕西医学杂志,2017,46(4):474475.
[2] 武宗琴,彭 勇,王英杰,等.中医内、外治法治疗湿疹的研究进展[J].世界临床药物,2017,17(3):149153.
[3] 孙志高,路军章,周杉京,等.中医药治疗湿疹的研究进展[J].中华中医药杂志,2017,36(8):299301.
[4] 裴小平,杨 斌,陈文静,等.白鲜皮提取液对湿疹模型小鼠血清IL10、IL17和IL22含量的影响[J].皮肤性病诊疗学杂志,2017,24(3):168172.
[5] 章 莉,高宜云,顾科峰,等.复方紫草油对湿疹模型小鼠血清IL2、TNFα水平的影响[J]. 浙江中西医结合杂志,2016,26(9):798800.
[6] 王永慧,王思农,肖静秋,等.藏药二十五味儿茶凝胶对大鼠慢性湿疹模型LTB4、LTC4因子的影响[J].中国皮肤性病学杂志,2018,32(5):568570.
[7] 赵 辨.湿疹面积及严重度指数评分法[J].中华皮肤科杂志,2004,37(1):34.
[8] Lundin S,Wahlgren CF,Bergstra MA,et al. Use of emollients and topical glucocorticoids among adolescents with eczema datafrom the populationbased birth cohort BAMSE[J]. Br J Dermatol,2018:179.
[9] Wan HL, Chen HZ, Shi XQ. Study on effect of traditional Chinese medicine Jianpi Chushi decoction and ointment on chronic eczema[J].Asian Pacific journal of tropical medicine, 2016, 9(9): 920923.
[10] Zhao JP, Feng XY, Ma XJ. Clinical effects of Wenyang Sanhan Chushi description in rheumatoid arthritis treatment[J]. Pharmacol Clin Chin Materia Medica,2015,1:254255.
[11] 朱颖玲,王 毅,周丽娜,等.中西医结合治疗尿毒症合并皮肤瘙痒症疗效观察[J].陕西中医,2014,35(4):401402.
[12] 孟子琦,吴嘉瑞,杨艳平,等.基于网络药理学的“白鲜皮地肤子”药对治疗湿疹作用机制研究[J].中国医院用药评价与分析,2018,18(6):725728.
[13] Berker M, Frank LJ, Gessner AL, et al. Allergies-AT cells perspective in the era beyond the TH1/TH2 paradigm[J].Clinical Immunology, 2017, 174: 7383.
[14] 李 陈,常 克,杨 静,等.紫草及紫草制剂的抗炎作用研究进展[J].世界中医药,2018,13(6):7478.
[15] 田 波,李春娟.五苓化湿汤治疗儿童顽固型湿疹的疗效及对血清白介素因子的影响[J]. 陕西中医,2017,38(11):15661567.
[16] Baci IS,Ruzicka T. IL31:A new key player in dermatology and beyond.[J]. Journal of Allergy & Clinical Immunology,2018:104109.
[17] 李奇俊,马军党.润燥止痒胶囊联合氯雷他定对慢性湿疹患者应激反应、炎症反应的影响[J].陕西中医,2018,39(10):14471449.
[18] AdamekGuzik T,Guzik TJ,CzerniawskaMysik G,et al. Urinary leukotriene levels are increased during exacerbation of atopic eczema/dermatitis syndrome. Relation to clinical status[J]. Allergy,2015,57(8):732736.
[19] Cascella R,Foti CV,Lepre T,et al. Full sequencing of the FLG gene in Italian patients with atopic eczema:evidence of new mutations,but lack of an association.[J]. Journal of Investigative Dermatology,2011,131(4):982984.
[20] Zhu Y,Underwood J,Macmillan D,et al. Persistent kallikrein 5 activation induces atopic dermatitislike skin architecture independent of PAR2 activity[J]. Journal of Allergy & Clinical Immunology,2017,140(5):207212.